Bruno Bulic

1 result

Novartis estimates that only 600 patients a year would be eligible for its new $375,000 therapy. Photograph: Vivek Prakash/Reuters

Novartis’s new gene-modifying cancer therapy’s $475,000 (€399,100) per patient sticker price has drawn fire from advocate groups calling for cheaper d(...)